$IMMX
Immix Biopharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$12.50
▼-1.73%-$0.220
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImmix Biopharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is IMMX down today? It is at $12.50 (-1.73%), and our scanner flagged it 158 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMMX spikes, and full due diligence on IMMX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IMMX 158 times in the last 30 days. Create a free account to track $IMMX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IMMX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMMX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Buchan Jane Director | Acquired (grant/award) | +6K | added 28% | 29K | n/a | May 22, 26 |
Hsu Jason Director | Acquired (grant/award) | +6K | added 0.7% | 899K | n/a | May 22, 26 |
Chudnovsky Yekaterina Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | May 22, 26 |
Ng Carey Director | Acquired (grant/award) | +6K | added 31% | 26K | n/a | May 22, 26 |
Marquet Magda Director | Acquired (grant/award) | +6K | added 14% | 52K | n/a | May 22, 26 |
Chang Nancy T Director | Acquired (grant/award) | +6K | added 1.5% | 428K | n/a | May 22, 26 |
Adams Helen C. Director | Acquired (grant/award) | +6K | added 3.6% | 181K | n/a | May 22, 26 |
Morris Gabriel S Officer | Bought (open market) | +770 | added 0.3% | 291K | $5K at $6.58 | Dec 10, 25 |
Rachman Ilya M Officer | Bought (open market) | +746 | added <0.1% | 1.14M | $5K at $6.67 | Dec 10, 25 |
Morris Gabriel S Officer | Other | 156K 0.2% of company | added 53% | 451K | $125K at $0.800 | Dec 8, 25 |
Rachman Ilya M Officer | Bought (open market) | +3K | added 0.2% | 1.14M | $5K at $2.02 | Sep 17, 25 |
Morris Gabriel S Officer | Bought (open market) | +3K | added 0.9% | 291K | $5K at $1.97 | Sep 16, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IMMX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMMX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IMMX last traded at $12.50, down 1.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Immix Biopharma, Inc. Common Stock (IMMX) is next expected to report earnings on Friday, November 6, 2026, about 47 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IMMX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMMX 158 times in the last 30 days.
IMMX (Immix Biopharma, Inc. Common Stock) trades on XNAS, with a market cap of about $894M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMMX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMMX discussion
Sign in to ask a question or join the discussion.